BIONIME together with qualified experts in the field of diabetes have initiated and completed several SMBG patents during the last few years. Nevertheless, innovation and creativity will continue to characterize BIONIME’s efforts in the SMBG field.
|2017||• Feb - GM700 Pro won Taiwan Excellence Award|
• Aug - Certified by Brazil's National Health Surveillance Agency and received ANVISA Certificate
• Apr - Successfully obtained Good Manufacturing Practices (GMP) Certification from SGS for additional products including Uric acid and Cholesterol Detection detections.
• Dec - Received capital injection by private placement from Dongbao Pharmaceutical Co., Ltd
• Apr - Obtained new patent in China regarding "Insulin measuring pen with biological sensors".
• Jan - Established subsidiary in Pingtan, China
• Dec - Received new patent in Germany for “Measuring Device for an Analyte”.
• Jun - Members of the Diplomatic and Economic Representatives inTaiwan Visit Bionime for Exchange International Business and Bionime’s Competitive Advantages
• Jan - GM720 won Taiwan Excellence Award
• Oct - GM720 won National Industrial Innovation Award
• Sep - GD500 won National Invention and Creation Award
• Sep - Pass Taiwan GMP certification
• Mar - Mylife Unio Won Reddot Design Award
• Mar - New Building & Factory completion
• Dec - New Product “Mylife Unio” shipped to European Market
• Jan - GE Selects Bionime to Launch Innovative Diabetes Solutions
• Dec - Bionime acquires the Innovation Award from Taiwan Ministry Economic Affair.
• Sep - BIONIME has passed certification of OHSAS18001.
• July - Acquisition land property for extending operation
• July - Pass Taiwan AEO Certification
• Mar - Strategic global cooperation with GE during term of Licensing Agreement in diabetes technology.
• Dec - Become a public company and traded officially as a hi-tech company on the TWSE.
• Sep - Granted the highest award of Taipei Biotech competition.
• Aug - Approved to apply a high-tech list company by Industrial Development Bureau, Ministry of Economic Affairs.
• Feb - Set up Bionime Australia Pty Limited.
• Jul - Granted SFDA of RightestGM100, 110.
• May- Launch of Rightest GM550 in Europe.
• Apr - Pass KGMP audit.
• Jan - Listed on Emerging Stock Market (#4737)
• Oct - In strategic alliance with Ypsomed, a Switzerland-based solution provider of injection system for diabetes treatment.
• Sep - Granted FDA 510(K) of Rightest GM100, 110.
• Aug - First shipment of ODM products.
• Mar - Launch new Lancing Device to the market.
• Feb - Set up BIONIME USA Corporation.
• Aug - Passed ISO 13845 and CMDCAS audit.
• July - Passed TNO Certification.
• Mar - Launch Rightest GM100.
|2006||• Feb - Set up BIONIME (ShenZhen) Co., Ltd.|
• Aug - Granted China SFDA of Rightest GM300 Aug.
• Jun - Passed Taiwan GMP Certification Jun.
• May - Launch Rightest GM300
• Apr - Set up BIONIME GmbH Switzerland Apr.
• Jan - Granted FDA 510(K) of Rightest GM300.
• Dec - Set up BIONIME INCORPORATED Dec.
• Nov - Granted CE Certification and passed ISO13485 Certification.
• Oct - The development of the first generation of blood glucose meter was completed.
• Apr - BIONIME was founded at Dali City, Taichung County Apr.